Top Brand


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
Customers also bought
Rytstat 50mg Tablet 6s is an innovative, oral medication belonging to a new class of drugs known as HIF-PH (Hypoxia-Inducible Factor-Prolyl Hydroxylase) inhibitors. It is primarily used to treat anaemia in adult patients with Chronic Kidney Disease (CKD), including those who are on dialysis and those who are not. Unlike traditional treatments for anaemia that require injections (such as Erythropoiesis-Stimulating Agents), Desidustat is a convenient oral tablet. It works by mimicking the body's natural response to low oxygen levels (hypoxia), stimulating the production of red blood cells and improving the body’s ability to use its iron stores.
Rytstat 50mg Tablet 6s contains Desidustat, an oral medication specifically developed to manage anaemia in adults with chronic kidney disease (CKD). Anaemia is a common complication of CKD, caused primarily by reduced production of erythropoietin, a hormone produced by the kidneys that stimulates red blood cell formation.
Desidustat belongs to a class of drugs called HIF prolyl hydroxylase inhibitors (HIF-PHIs). It works by stabilising hypoxia-inducible factors (HIFs), which leads to increased endogenous erythropoietin production and enhanced red blood cell synthesis in the bone marrow. This action helps raise haemoglobin levels and improve the body’s oxygen-carrying capacity, alleviating symptoms such as fatigue, weakness, and shortness of breath associated with anaemia.
Rytstat 50mg Tablet 6s is suitable for adults with CKD, including those on dialysis, and can be used as part of a comprehensive anaemia management plan. It is important to take the medication exactly as prescribed and undergo regular monitoring of haemoglobin, iron levels, and other blood parameters to ensure effectiveness and reduce the risk of side effects.
Rytstat 50mg Tablet 6s is specifically indicated for:
Treating low red blood cell counts in patients with stage 3, 4, or 5 CKD.
Managing haemoglobin levels in patients undergoing regular hemodialysis or peritoneal dialysis.
Providing a needle-free option for patients whose kidneys are failing but who do not yet require dialysis.
Helping patients with CKD better utilise their internal iron stores by suppressing hepcidin.
Replaces painful and frequent injections with a simple oral tablet taken three times a week.
Stimulates the body to produce its own Erythropoietin in a way that mimics natural high-altitude adaptation.
Lowers hepcidin levels, making both dietary iron and iron supplements significantly more effective.
Works efficiently whether a patient is on dialysis or managing their kidney disease through other conservative methods.
Provides a controlled increase in haemoglobin, helping patients avoid the effects of fluctuating red blood cell counts.
When taken as directed, Rytstat 50mg Tablet 6s is generally safe. Side effects are usually rare, mild, and temporary.
The safety of Desidustat during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare professional.
It is not known whether Desidustat passes into breast milk. Breastfeeding mothers should only use it under medical supervision.
Desidustat is not known to affect alertness or the ability to drive or operate machinery.
Use with caution in patients with severe liver impairment. Liver function may need monitoring during treatment.
Desidustat is used in patients with chronic kidney disease, but close monitoring is necessary to avoid excessive haemoglobin increase or related complications.
Alcohol may worsen anaemia-related fatigue or interfere with overall health. Limit consumption while on Desidustat.
Desidustat can be taken with or without food. Consistent timing with meals is recommended to maintain adherence.
Maintain a balanced diet rich in iron and nutrients, and follow your healthcare provider’s advice regarding exercise and hydration to optimise treatment benefits.
Store at room temperature (below 30°C).
Protect from light and moisture by keeping the tablets in their original blister pack.
Keep out of reach of children.
The starting dose is typically 100mg taken three times a week. Your doctor will adjust this dose (up or down) based on your blood haemoglobin levels, aiming for a target range of 10 to 12 g/dL.
An overdose can lead to an excessively high haemoglobin level (Polycythemia), which increases the risk of stroke or heart attack.
Therapeutic Class
Anti-anemia agent
Action Class
Stimulates endogenous erythropoietin production and improves iron utilisation
Chemical Class
HIF prolyl hydroxylase inhibitor (HIF-PHI)
Habit Forming
No
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
More Medicines By Manufacturer
More Medicines With Salt
Top Selling Medicines
Top Selling Devices
Flat ₹100 off on first app order | Use Code: APP100 |
Flat ₹100 off on first app order
USE CODE: APP100

Download Now